Cargando…
COVID-19: A Brief Overview of the Discovery Clinical Trial
The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the Europe...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243102/ https://www.ncbi.nlm.nih.gov/pubmed/32290348 http://dx.doi.org/10.3390/ph13040065 |
| _version_ | 1783537366240067584 |
|---|---|
| author | Vanden Eynde, Jean Jacques |
| author_facet | Vanden Eynde, Jean Jacques |
| author_sort | Vanden Eynde, Jean Jacques |
| collection | PubMed |
| description | The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project. |
| format | Online Article Text |
| id | pubmed-7243102 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72431022020-08-13 COVID-19: A Brief Overview of the Discovery Clinical Trial Vanden Eynde, Jean Jacques Pharmaceuticals (Basel) Opinion The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project. MDPI 2020-04-10 /pmc/articles/PMC7243102/ /pubmed/32290348 http://dx.doi.org/10.3390/ph13040065 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Opinion Vanden Eynde, Jean Jacques COVID-19: A Brief Overview of the Discovery Clinical Trial |
| title | COVID-19: A Brief Overview of the Discovery Clinical Trial |
| title_full | COVID-19: A Brief Overview of the Discovery Clinical Trial |
| title_fullStr | COVID-19: A Brief Overview of the Discovery Clinical Trial |
| title_full_unstemmed | COVID-19: A Brief Overview of the Discovery Clinical Trial |
| title_short | COVID-19: A Brief Overview of the Discovery Clinical Trial |
| title_sort | covid-19: a brief overview of the discovery clinical trial |
| topic | Opinion |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243102/ https://www.ncbi.nlm.nih.gov/pubmed/32290348 http://dx.doi.org/10.3390/ph13040065 |
| work_keys_str_mv | AT vandeneyndejeanjacques covid19abriefoverviewofthediscoveryclinicaltrial |